| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Xilio Therapeutics, Inc.
13G
XLO · 98422T100
|
9.0% |
2/18/2025
Event 2/11/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.